Want to become the sole advertiser on this website? Just £500 GBP / month.
Contact us today.
Short Interest Update USOCGN

OCGN Short Interest Remains Elevated

Ocugen, Inc. (OCGN) continues to see high short interest at 32.1% of its float, with a days-to-cover ratio of 23.9, indicating persistent bearish pressure.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk September 30, 20261 min read
Company
Ocugen, Inc.
Borrow Fee
2.1%
Short % Float
32.1%
Days to Cover
23.9

Persistent Bearishness in OCGN

Ocugen, Inc. (OCGN) remains a heavily shorted stock, with 32.1% of its float currently held by short sellers. The days-to-cover ratio of 23.9 suggests that the short position is not only large but also difficult to unwind quickly without significantly impacting the stock price. This setup is a classic indicator of a crowded trade that could be susceptible to a squeeze if market sentiment shifts.

Market Outlook

Traders are closely watching OCGN for signs of a reversal. The high utilization of lendable shares and the elevated short interest suggest that the cost of maintaining these positions remains a factor. As the stock trades at $1.35, the high short interest relative to the float makes it a volatile name to watch for any potential short-covering rallies.

Source

Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Interest#Squeeze Risk#Biotech

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog